Precision BioSciences (DTIL)

Precision BioSciences (DTIL) Financial Statements


Precision BioSciences Financial Overview

Precision BioSciences's market cap is currently ―. The company's EPS TTM is $-9.796; its P/E ratio is -1.01; Precision BioSciences is scheduled to report earnings on August 15, 2024, and the estimated EPS forecast is $-2.11. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 17.58M$ 13.12M$ 19.79M$ 8.78M$ 10.60M
Gross Profit$ 17.58M$ 13.12M$ 19.79M$ 8.78M$ 10.60M
EBIT$ -1.22M$ -11.53M$ -11.34M$ -24.54M$ -29.94M
EBITDA$ 316.00K$ -9.57M$ -9.00M$ -22.14M$ -37.74M
Net Income Common Stockholders$ 8.59M$ -8.08M$ -11.89M$ -25.06M$ -28.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 137.77M$ 122.23M$ 137.79M$ 158.13M$ 189.58M
Total Assets$ 184.74M$ 164.34M$ 181.70M$ 204.50M$ 238.17M
Total Debt$ 31.05M$ 23.86M$ 27.99M$ 26.60M$ 27.04M
Net Debt$ -106.71M$ -98.37M$ -109.81M$ -131.53M$ -162.54M
Total Liabilities$ 147.53M$ 135.28M$ 147.66M$ 164.32M$ 177.74M
Stockholders Equity$ 37.21M$ 29.06M$ 34.04M$ 40.18M$ 60.43M
Cash Flow-
Free Cash Flow$ -19.01M$ -23.48M$ -22.14M$ -31.98M$ -22.48M
Operating Cash Flow$ -18.98M$ -23.09M$ -21.13M$ -31.46M$ -21.84M
Investing Cash Flow$ -26.00K$ 7.56M$ -1.06M$ -721.00K$ -632.00K
Financing Cash Flow$ 40.09M$ -34.00K$ 1.85M$ 741.00K-
Currency in USD

Precision BioSciences Earnings and Revenue History

Precision BioSciences Debt to Assets

Precision BioSciences Cash Flow

Precision BioSciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis